Canada Journal – News of the World Articles and videos to bring you the biggest Canadian news stories from across the country every day
A recent study shows that the anti-seizure medication valproic acid (Depakote) that’s prescribed to prevent seizures and may also be used to control mood, could help to reduce the risk of some head and neck cancers.
“A 34 percent risk reduction for the development of head and neck cancer with valproic acid use could result in the prevention of up to approximately 16,000 new cases and 3,000 to 4,000 annual deaths in the U.S. alone,” said Dr. Johann Christoph Brandes, who headed the study. “Head and neck cancer is an important global health crisis, and low cost and low-toxicity prevention strategies like valproic acid use have a high potential impact on pain, suffering, costs, and mortality associated with this disease.”
Researchers began to study valproic acid because medical research has proved it can affect certain tumors. Brandes’s team studied veterans who took valproic acid under brand name drugs like Epilim, Depakote, and Valpro.
Although valproic acid reduced the rates of head and neck cancer in the study, it did not affect the rates of other cancers such as lung, prostate ,or colon cancer. Researchers believe that the study could help save lives, as over 40,000 Americans are diagnosed with head or neck cancer each year. One fourth of those diagnosed with the disease die every year.
Agencies/Canadajournal
